Featured Research

from universities, journals, and other organizations

New Predictor Of Heart Disease Risk Found: Damage Caused By Block Of Critical "Protector" Protein In Blood Cell Wall

Date:
August 27, 2002
Source:
University Of California, Davis - Medical Center
Summary:
Cardiovascular research is increasingly showing that a new predictor of heart disease risk, c-reactive protein, is just as important as monitoring cholesterol levels to prevent and treat heart disease and other ills, including stroke, sudden death and peripheral vascular disease. Now, UC Davis physicians have discovered that this protein is not just a marker for heart disease, but that it actually damages the blood vessel wall by blocking a critical "protector" protein and by promoting plaque formation.

SACRAMENTO, Calif. -- Cardiovascular research is increasingly showing that a new predictor of heart disease risk, c-reactive protein, is just as important as monitoring cholesterol levels to prevent and treat heart disease and other ills, including stroke, sudden death and peripheral vascular disease. Now, UC Davis physicians have discovered that this protein is not just a marker for heart disease, but that it actually damages the blood vessel wall by blocking a critical "protector" protein and by promoting plaque formation.

The finding, published in the September 17 issue of the journal Circulation (available on the Web at http://www.circulationaha.org ), describes a new molecular pathway that stimulates plaque formation. The work is important because it provides a new target for drug development efforts, explains why cholesterol screening is not enough to accurately assess heart disease risk, and underscores the need to use c-reactive protein screening to more accurately assess at-risk populations.

In their series of experiments, UC Davis researchers found that c-reactive protein inhibits the activity of a very critical "protector" enzyme in the blood vessel wall. This protector enzyme, called eNOS, or endothelial nitric oxide synthase, produces nitric oxide, which works to keep blood vessels healthy and heart disease at bay by preventing plaques from adhering to blood vessel walls, keeping coronary arteries dilated and inhibiting constriction of smooth muscle cells.

At the molecular level, c-reactive protein decreases the stability of eNOS messenger RNA and prevents the activation of its second-messenger molecule, cyclic GMP. These events prevent eNOS from producing its protective biological effects. C-reactive protein also promotes white-blood-cell binding to blood vessel walls and stimulates the release of other adhesion molecules, including intercellular adhesion molecule 1, or 1CAM-1, and vascular cell adhesion molecule, or VCAM-1, which further promote plaque build-up.

"Without the protective effects of eNOS and the plaque-promoting effects of c-reactive protein, the blood vessel wall is ripe for the development of heart disease," said Ishwarlal Jialal, professor of pathology and director of the Laboratory for Athersclerosis and Metabolic Research at UC Davis School of Medicine and Medical Center. "The attachment of white blood cells and their entry into the vessel wall are early events that lead to fatty streaks or early plaque formation."

These novel findings at the molecular and cellular level support the work of other investigators who have shown that patients with increased levels of c-reactive protein have impaired blood vessel function, as measured by forearm blood flow. The findings also support current efforts to develop new screening guidelines.

"By using existing high-sensitive assays to measure c-reactive protein levels, we can better identify individuals who are truly at risk for heart disease and get them started on prescription drugs, lifestyle changes or other treatments as necessary to reduce these protein levels and to prevent disease," said Jialal, who is the Robert E. Stowell Endowed Chair in Experimental Pathology. "High risk groups include postmenopausal women and individuals with a positive family history of premature heart disease, hypertension, smoking or metabolic syndrome, a disorder characterized by a disproportionate amount of abdominal fat, elevated blood pressure, blood sugar and triglycerides and low levels of HDL, the "good" kind of cholesterol. Testing would be beneficial to individuals in these groups, especially when cholesterol levels are within the normal range and other risk factors and assessment measures indicate an intermediate level of risk for heart disease."

Other investigators at UC Davis contributing to this study include Sridevi Devaraj, assistant professor of pathology, and Senthil Venugopal, research fellow. Measures of eNOS enzymatic activity was performed in the laboratory of Philip Shaul, University of Texas Southwestern Medical Center at Dallas.

This research was supported with a grant from the National Institutes of Health.


Story Source:

The above story is based on materials provided by University Of California, Davis - Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of California, Davis - Medical Center. "New Predictor Of Heart Disease Risk Found: Damage Caused By Block Of Critical "Protector" Protein In Blood Cell Wall." ScienceDaily. ScienceDaily, 27 August 2002. <www.sciencedaily.com/releases/2002/08/020827062910.htm>.
University Of California, Davis - Medical Center. (2002, August 27). New Predictor Of Heart Disease Risk Found: Damage Caused By Block Of Critical "Protector" Protein In Blood Cell Wall. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2002/08/020827062910.htm
University Of California, Davis - Medical Center. "New Predictor Of Heart Disease Risk Found: Damage Caused By Block Of Critical "Protector" Protein In Blood Cell Wall." ScienceDaily. www.sciencedaily.com/releases/2002/08/020827062910.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins